The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Androgen Deprivation Therapy (ADT) Market Research Report 2025
Synopsis
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.
The global Androgen Deprivation Therapy (ADT) market was valued at US$ 5773.1 million in 2023 and is anticipated to reach US$ 8369.7 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Androgen Deprivation Therapy (ADT) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Androgen Deprivation Therapy (ADT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Deprivation Therapy (ADT).
Report Scope
The Androgen Deprivation Therapy (ADT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgen Deprivation Therapy (ADT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgen Deprivation Therapy (ADT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.
The global Androgen Deprivation Therapy (ADT) market was valued at US$ 5773.1 million in 2023 and is anticipated to reach US$ 8369.7 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
North American market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Androgen Deprivation Therapy (ADT) in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Androgen Deprivation Therapy (ADT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Deprivation Therapy (ADT).
Report Scope
The Androgen Deprivation Therapy (ADT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Androgen Deprivation Therapy (ADT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Androgen Deprivation Therapy (ADT) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2019-2030)
2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Region
2.2.1 Global Androgen Deprivation Therapy (ADT) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2019-2024)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030)
2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2019-2024)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2019-2024)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2023
3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2019-2024)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2019-2024)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
6.2 North America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024)
8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
9.2 Latin America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2019-2030)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024)
10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.2.5 Astellas Pharma Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Detail
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.4.5 Novartis International Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Veru
11.6.1 Veru Company Detail
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.6.5 Veru Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 Orion
11.10.1 Orion Company Detail
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.10.5 Orion Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2024)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2025-2030)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2019-2024)
Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2019-2024)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2025-2030)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2019-2024)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2025-2030)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2025-2030) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 50. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Astellas Pharma Company Detail
Table 53. Astellas Pharma Business Overview
Table 54. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 55. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 56. Astellas Pharma Recent Development
Table 57. Johnson & Johnson Company Detail
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 60. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Novartis International Company Detail
Table 63. Novartis International Business Overview
Table 64. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 65. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 66. Novartis International Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Androgen Deprivation Therapy (ADT) Product
Table 70. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Veru Company Detail
Table 73. Veru Business Overview
Table 74. Veru Androgen Deprivation Therapy (ADT) Product
Table 75. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 76. Veru Recent Development
Table 77. Sanofi Company Detail
Table 78. Sanofi Business Overview
Table 79. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 80. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
Table 85. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Androgen Deprivation Therapy (ADT) Product
Table 90. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Orion Company Detail
Table 93. Orion Business Overview
Table 94. Orion Androgen Deprivation Therapy (ADT) Product
Table 95. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 96. Orion Recent Development
Table 97. AstraZeneca Company Detail
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Androgen Deprivation Therapy (ADT) Product
Table 100. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2019-2024) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2023 VS 2030
Figure 3. Medicine Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Androgen Deprivation Therapy (ADT) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2023 VS 2030
Figure 15. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2023
Figure 16. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2023
Figure 18. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 20. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 24. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2019-2030)
Figure 32. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 40. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2019-2030)
Figure 44. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 47. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 49. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 51. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 52. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 54. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 55. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 56. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
